Share this:
|
Issue 27 • November 2024 PMI Grants Team
| |
| Retirement of NIH’s Automated Just-in-Time Email Notification
The automated Just-In-Time email, generated by the eRA system and sent to applicants for all applications that receive an overall impact score of 30 or less, is retired effective October 1, 2024.
Official notification of the need for JIT material(s) will continue to be sent directly by NIH staff from the awarding Institute/Center to those who are required to provide the material(s). View
| |
| Funding Opportunities by Agency
| |
Discovery Boost Grants (DBG) high-risk, high-reward exploratory cancer research. Awards are for up to 2 years with $135,000 a year for direct costs, plus 10% allowable indirect costs. Due: 04/01/25
Mission Boost Grants (MBG) Stage I Mission Boost: $135,000/year for two years direct costs, plus 10% indirect costs. Stage II Mission Boost: Applicants may propose up to 18 months and $545,000 for direct costs, plus 10% indirect costs. Due: 04/01/25
Research Scholar Grants Awards are for up to 4 years with up to $215,000/year for direct costs, plus 10% allowable indirect costs. Due: 04/01/25
Postdoctoral Fellowship $66,000 Yr 1, $68,000 Yr 2, $70,0000 Yr 3, and additional $4,000/year Fellowship allowance. Due: 04/01/25
| |
2025 Innovative Project Award $100,000/year including 10% indrects for two years. Pre-proposal due 12/05/24. Full application by invitation: 03/06/25
| |
Clinical Research Investigator-Initiated Awards Applicants submitting proposals above $250,000/year in total costs (10% IDC maximum allowed) should speak with Foundation staff prior to submitting a letter of intent. Awarded up to three years. LOI: 12/05/2024; full application: 02/13/2025
Senior Research Awards up to $118,182 per year, 10% indirect costs. Duration of award is one to three years. LOI: 12/05/24; full application: 02/13/25
Litwin IBD Pioneers $130,000 including 10% indirects for clinical trials; and up to $110,000 including 10% indirects for lab-based studies. Up to two years. LOI: 12/05/24; full application: 02/13/25
Career Development Awards Award salary will match applicants’ institutional salary (salaries may be supplemented by the applicant’s institution), depending on postgraduate year (PGY) level, up to $60,000 per year and fringe - up to $15,000 per year, plus $27,500 for non-salary/fringe expenses. LOI: 12/05/24; full application: 02/13/25
Research Fellowship Awards Maximum award per year: $70,000 for one to three years including salary, fringe, and non-salary/fringe expenses. LOI: 12/15/24; full application: 02/13/25
| |
Damon Runyon Physician-Scientist Training Award Award period is four years, total award: $460,000. Additionally, The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee. Applications due by 12/02/24
Damon Runyon Clinical Investigator Award *Institutional nomination required* $200,000/year for three years. The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee. Internal applications due: 11/13; Full applications due: 02/03/25
Damon Runyon Fellowship Award Stipend: $70,000 Yr 1, $72,000 Yr 2, $74,000, Yr 3, and $76,000 Yr 4 plus 2K/year expense allowance. The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee. Applications due by 03/17/25
| |
|
NOT-OD-23-032 Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards Up to 70K. Deadlines vary by awarding IC.
PAR-23-275 NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Application budgets are not limited but need to reflect the actual needs of the proposed project. Next AIDS deadline: 01/07/25, Standard due date: 02/05/25
PAR-24-075 Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) Application budgets are not limited but need to reflect the actual needs of the proposed project. Next due date:01/28/25
PAR-23-145 Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional) up to $250,000 direct costs/year. Due: 02/03/25
PAR-23-055 Co-infection and Cancer (R01 Clinical Trial Not Allowed) Application budgets are not limited but need to reflect the actual needs of the proposed project. Due: 02/05/25
PA-24-194 NIH Pathway to Independence Award (Parent K99/R00 – Independent Clinical Trial Not Allowed) Salary and research costs may be requested to the level provided by the awarding Institute or Center plus indirects. Due: 02/12/25
PAR-24-225 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) Salary and research costs may be requested to the level provided by the awarding Institute or Center plus indirects. Due: 02/12/25
PAR-23-056 Co-infection and Cancer (R21 Clinical Trial Not Allowed) The combined budget for direct costs for the two-year project period may not exceed $275,000 D ue: 02/16/25
PAR-24-037 HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) Up to $2,500,000 directs/year. LOI: 30 days prior to application deadline. Due: 03/13/25
PAR-23-024 Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional) Direct costs are limited to $350,000 per year. Due: 05/01/25
PAR-23-246 Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) Up to $475,000 in direct costs/year. Due: 05/05/25
| |
|
NIH Standard Deadlines
F series (New, Renewal, Resubmission) Routing: 11/26/24, Sponsor: 12/08/24
R13, U13 (New, Renewal, Resubmission, Revision) Routing: 12/02/24, Sponsor: 12/12/24
January
P Series (New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25
R18, U18, R25 (New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25
T & D Series (New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25
C06/UC6
(New, Renewal, Resubmission, Revision) Routing: 01/14/25, Sponsor: 01/25/25
February
R01 (New) Routing: 01/24/25, Sponsor: 02/05/25
U01 (New) Routing: 01/24/25, Sponsor: 02/05/25
K Series (New) Routing: 01/31/25, Sponsor: 02/12/25
R21 (New) Routing: 02/04/25, Sponsor: 02/16/25
March
R01 (Renewal, Resubmission, Revision) Routing: 02/21/25, Sponsor: 03/05/25
U01 (Renewal, Resubmission, Revision) Routing: 02/21/25, Sponsor: 03/05/25
K Series (New) Routing: 02/28/25, Sponsor: 03/12/25
R21 (New) Routing: 03/04/25, Sponsor: 03/16/25
F series (New, Renewal, Resubmission) Routing: 03/27/25, Sponsor: 04/08/25
R13, U13 (New, Renewal, Resubmission, Revision) Routing: 04/01/25, Sponsor: 04/12/25
| |
|
Additional Funding Opportunities:
| |
| Additional information is available via the following links:
| |
| Missing PMCIDs and other common errors on proposals
The PMI grants team encourages applicants to review items often overlooked for compliance on NIH proposals. View...
| |
|
Planning a proposal submission in the next 2 - 3 months? In an effort to better serve you, the PMI grants team requests that PIs and Fellows notify us as far in advance as possible of submission plans. This ensures ample time to complete departmental requirements and also route to OSP for review by their deadline. Here is the link to the new SRS intake tool for new/resubmission requests: View...
| |
|
Have a pressing inquiry regarding submissions or post-award items? We're here to help! Candice Stevens, Associate Director, Lauren Milam, Sr Financial Manager, Edith Ashcraft, Sr Financial Analyst, Doug Smith, Sr Financial Analyst, Leigh Thompson, Budget Accounting Analyst Post-Award, Karin Sack, Grants Manager, and Alethea Kelly, Grants Manager.
| |
|
|
|
|
Vanderbilt University Medical Center 1161 21st Ave S | Nashville, TN 37232 US
|
|
